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1st Editorial Decision 13 September 2010 
Thank you for submitting your manuscript on the SlmA nucleoid exclusion factor and its 
mechanism for consideration by The EMBO Journal. We have now received the reports of three 
expert referees, which you will find copied below. As you will see, all three reviewers consider your 
findings on this topic and their implications potentially important, and would in principle support 
publication in The EMBO Journal pending adequate revision. Nevertheless they do raise a number 
of substantive issues that would need to be addressed prior to publication. While many of these 
points pertain to presentational aspects (including discussion, interpretation, figure assembly, and 
inclusion of data currently not shown), there are also some more significant issues regarding further 
and more decisive support for the in vivo significance of the data and the currently proposed model 
of SlmA action (see especially referee 2's general points but also referee 3's 'other specific' points 10 
& 11). 
 
Should you be able to satisfactorily address these main issues, as well as the more specific and 
presentational points raised by all three reports, we should be happy to consider a revised version of 
the manuscript further for publication. In this respect, although I realize that decisively determining 
how SlmA may inhibit Z ring assembly may require more work than is within the scope of the 
present submission, I nevertheless agree that the current study would make a much more compelling 
contribution if at least some further support for the suggested model could be obtained at this stage. 
I would thus like to invite you to prepare such a revision, keeping in mind that it is EMBO Journal 
policy to allow a single round of major revision only, and that it will thus be important to diligently 
answer to all the various major and minor points raised at this stage. When preparing your revision, 
please also bear in mind that your letter of response will form part of the Peer Review Process File, 
and will therefore be available online to the community in the case of publication (for more details 
on our Transparent Editorial Process initiative, please visit our website: 
http://www.nature.com/emboj/about/process.html). Finally, please also briefly specify the individual 
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author contributions, either in the acknowledgements section or in an adjacent separate section, as 
we are attempting to adopt this as a common policy now. In any case, please do not hesitate to get 
back to us should you need feedback on any issue regarding your revision. 
 
Thank you for the opportunity to consider your work for publication. I look forward to your 
revision. 
 
Yours sincerely, 
Editor 
The EMBO Journal 
 
_____ 
 
REFEREE REPORTS: 
 
 
Referee #1 (Remarks to the Author): 
 
The work of Tonthat et al. studies an important unresolved point on the regulation of cell division in 
E. coli: the inhibition of the cell division protein FtsZ by SlmA. SlmA is responsible of stopping the 
Z-ring from forming over and constricting the unreplicated/unsegregated nucleoid. Although a 
previous study showed that SlmA binds the nucleoid and interacts directly with FtsZ, the way in 
which FtsZ was inhibited by it is still not understood. 
 
In this work Tonthat et al. first determined the structure of SlmA, assigning it to the TetR-family of 
repressors as previously suggested by its sequence. Using a screening protocol for sequence binding 
they found a consensus binding-site for SlmA, which they then confirm as the recognition site in the 
chromosome by chromatin precipitation and sequencing. By fluorescence polarization they showed 
that SlmA can simultaneously bind DNA and FtsZ. Finally they determined the structure of SlmA 
bound to FtsZ, finding that instead of precluding the formation of FtsZ filaments (as in previous 
models), SlmA promotes filament formation but pairs of these filaments are arranged in an anti-
parallel manner. The authors propose that this anti-parallel arrangement will inhibit the formation of 
higher order structures and therefore of the Z-ring (which require parallel organization of 
protofilaments), providing a mechanistic mode of action of SlmA on FtsZ. This work has been 
carefully thought and performed, and provides essential new information on the understanding of 
bacterial cell division. 
 
There are however few points that the authors should consider: 
 
1) When they perform the ChIP-Seq they identified 52 SlmA binding sites on the chromosome. It is 
not clear if having those many points in the chromosome would be enough to stop Z-ring formation. 
Some of these sites might not be on the surface of the nucleoid, and therefore hidden to FtsZ. The 
remaining may be restricted to a small region (the extension of their binding site, 12bp x 52 out of 
the 4.6 Mbp chromosome!), making a chance encounter with FtsZ unlikely. The authors seem to 
ignore this issue but they should provide their views about it. 
 
More extended protection of the nucleoid could be provided were the protein not to be restricted to 
the SBS sites. In a recent study of the Bacillus subtilis nucleoid occlusion protein, Noc (Wu et al. 
2009, EMBO J 28: 1940), it was suggested that binding of this protein extends further than its 
recognition site, covering more than 1kb around it. These proteins are very different, Noc is a 
member of the ParB-family known to form filaments on DNA, meanwhile SlmA is not expected to 
do so. On this point is interesting to note that SlmA overexpression has been reported to cause FtsZ 
to localize to the nucleoid (Bernhardt and de Boer 2005, Mol. Cell 18: 555), suggesting that the 
nucleoid can be further loaded with SlmA. Regardless of its predicted capacity, the extension of 
SlmA binding around SBS sites, if it does exist, should be evident in the analysis of the ChIP-Seq. 
This is an important attribute of the protein and the authors should be clear about it. 
 
2) The authors found that the SBS sites are not homogenously distributed throughout the 
chromosome. Long regions of it lack any of these sequences and this seems to be conserved within 
Enterobacteria. The authors use the macrodomain nomenclature of the chromosome to describe the 
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patterns they encounter (Espeli and Boccard 2006, J Struct Biol 156:304). This division of the 
chromosome in four discrete and independent regions was proposed by genetic and more recently 
microscopy studies, and implies that each of these macrodomains have different behaviours. 
Following this line of thought, it was previously proposed that one way in which SlmA might 
regulate division is by binding to all but the Ter macrodomain (Espeli and Bocard 2006). Tonthat et 
al. when mapping the SBS sites point out that the Ter macrodomain is free of them, but they did not 
mention that in K12 most of the Right macrodomain is also free of these sequences (Fig 4A), and in 
other strains even Ori macrodomain has extensive SBS free-zones (Fig 4B). Their results show that 
Ter macrodomain is not the only one with low-density SBS sequences, but they seem to ignore this 
fact. Why should the Right macrodomain be less densly populated by SBSs than the Left? The 
authors should explain these results and incorporate the implications in their model. 
 
3) When discussing the distribution of SBS sites on the chromosome, the authors consider a link 
between cell division and segregation. This section is misleading since it appears to suggest that 
there are signals controlling the timing of segregation. This goes against the current view on DNA 
segregation where the only factor determining the timing of segregation of a locus is the time of its 
replication (Nielsen et al. 2006, Mol Microbiol 61: 383; Wang et al 2006, Genes Dev 20: 1721). 
This conflict is maybe just a misunderstanding caused by the way it is written and may just need 
rewording of this section. These two processes most likely have a passive relation: as the 
chromosomal regions migrate out of the centre of the cell they push the unreplicated DNA towards 
midcell, positioning the Ter proximal regions at the center of the cell permits the formation of the Z-
ring. The timing of Z-ring formation can be simply explained in terms of the Min system and the 
position of the Ter proximal regions. To avoid confusion the respective lines should be clarified, and 
more evidence should be provided if a direct relation or switch controlling these two processes is 
proposed. 
 
4) An obvious link between cell division and the Ter region is the septal protein FtsK. This protein 
is a DNA translocase needed for resolution of dimer chromosomes at dif. The activity of FtsK is 
restricted to a region of 400 kb around dif and requires the septum to be assembled, and possibly 
also constricted (Corre and Louarn 2005, Mol Microbiol 56:1539; Bigot et al 2007, Mol Microbiol 
64: 1434). Considering the above it follows that for FtsK, as well as for the resolution of 
chromosome dimers, it is essential that the formation of the septum may be permitted at the Ter 
region. The FtsK homologue, SpoIIIE, can pump vast sections of the chromosome into the prespore, 
so an alternative way of thinking is that FtsK may serve to protect the Ter region from guillotining 
(by pumping DNA to the correct compartment) and therefore SlmA binding is not needed around 
this region. Given that FtsK and dimer resolution are strongly associated to the Ter region the 
authors should include them in their discussion. 
 
5) To obtain the structure of SlmA-FtsZ, the authors mixed 1:1 ratio of both proteins. In this 
structure a dimer of SlmA interacts with a pair of FtsZ molecules. Nevertheless in their model (Fig 
6C & 7) they show a single dimer of SlmA interacting with two FtsZ filaments. Although this could 
be possible, they don't discuss the alternative model in which more than one dimer of SlmA is 
present in between the FtsZ protofilaments. They should consider this alternative model or provide 
reasons to discard it. Note that this point relates to the first on the extension of SlmA in the regions 
around SBS sites. 
 
Minor points: 
ï At the end of page 5 the authors should use the full name of RMSD 
ï In page 8 the authors should explain the concept of macrodomains before using them for the 
interpretation of their results 
ï In page 12, it is mentioned that subtle changes in FtsZ polymer assembly may prevent Z-ring 
formation. They should be clearer on the kind of changes they have in mind. 
 
 
Referee #2 (Remarks to the Author): 
 
The manuscript further characterizes the E. coli nulceoid occlusion protein, SlmA. It confirms the 
previous report by Bernhardt & de Boer that SlmA is a TetR-like protein, and that it interacts with 
the cell division protein FtsZ directly. The authors have also identified SlmA binding sequences and 
shown that, like the Bacillus nucleoid occlusion protein Noc, the binding sequences are absent in the 
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Ter region. 
The results presented are very nice, and the manuscript is well written. However, a large part of the 
results are confirmational. This can be improved by exploring the in vivo significance of the SlmA 
crystal structure. The authors should verify the dimer interface using mutants on the interface and 
show that the mutant proteins can no longer dimerize, and that the mutants are non-functional in 
vivo. 
Intercalation of SlmA between FtsZ protofilaments is not sufficient to explain the inhibition of FtsZ 
ring assembly over the nuceloid. Although the two FtsZ filaments formed by the FtsZ molecules 
bound directly to the SlmA dimer are anti-parallel and so are not able to interact laterally between 
them, nothing prevents them from forming independent thick parallel filaments from the SlmA-free 
side, unless SlmA dimers come between all growing filaments. With only about 50 SlmA dimers 
scattered on the non-Ter part of the chromosome, which is few and far between, this is not very 
likely. 
The other issue that is not very clear is the role of DNA-binding. The results seem to suggest that the 
role of DNA-binding is purely topological and is not required for the activity of SlmA. If so, then 
any SlmA dimer that is not bound to the chromosome will interfere with FtsZ polymerization 
anywhere in the cytoplasm, including the mid-cell. I think the authors need to discuss this 
possibility. 
Minor points: 
1) Is the His-tag-SlmA used in this study functional in vivo? 
2) Page 3 Introduction, line 15: 'Data show that...' This has been suggested but no in vivo data has 
been shown. 
3) Page 5 last line: give full name for 'RMSD'. 
4) Page 6 line 12: what does it mean by 'become induced from their DNA sites'? 
5) Page 7, second paragraph about FP assay. Please add 1 or 2 sentences to explain the technique. 
6) Page 9 second section about SlmA binding to DNA & FtsZ: A control using DNA with mutated 
SlmA binding sites should be included. 
7) Page 13 line 12: change 'combined' to 'combining'? 
8) Page 14 line 8: change 'in to' to 'into'. 
9) Page 14 lines 10 - 13: move the sentence ' Notably.....' to the 'Result' section? 
10) Figure 6C: the figure legend refers this as 'SAXS structure of SlmA-FtsZ...' This is misleading 
because the SAXS structure does not show FtsZ polymers. Should it be referred to as a model? 
11) Figure legend to Fig 7, the last sentence, and the Abstract: Is it known that Z-ring formation 
requires Z-protofilamens to be in parallel? 
12) Supp Materials & Methods, line 4: 
Full stop between 'WM3363 WM3363'. 
13) Supp Materials & Methods, line 16: should be 'with', not 'is'. 
14) Figure legend to S2, first line: should be 'into', not 'in to'. 
15) The models in FigS5A and Fig 6A are slightly different. Does that indicate conformational 
change upon DNA binding? 
16) Do SAXS analyses give information on the interaction interface? 
 
 
Referee #3 (Remarks to the Author): 
 
The paper Tonthat et al. is an interesting and significant contribution to its field. First, the crystal 
structure of the E. coli SlmA protein reveals it to be a TetR family member. While the structure is 
very similar to numerous previous structures, the novelty here is that it is believed to be the first 
member of the family whose principle role is not in transcriptional regulation. Previous studies have 
shown SlmA to be a "nucleoid occlusion" (NO) factor, which prevents cell division from occurring 
prematurely in the region of the cell occupied by the replicating chromosome. To explore the 
mechanism of SlmA's action, the authors identify and characterize the DNA sequence-specific 
binding of SlmA in vitro. This work corresponds well with the author's other approach, which maps 
the binding sites in vivo. These studies need to be presented more rigorously (more on this below), 
but these are important steps in the field. The absence of binding sites in the terminus region 
suggests that once replication/segregation of the chromosome has reached this region then NO is 
releaved in this region of the chromosome, which is known to be located near the mid-cell division 
site at this stage of the cell cycle. These findings are new for the E. coli field, although similar 
findings were made previously in the analogous B. subtilis system, as acknowledged by the authors. 
The final part of the paper identifies and characterizes the simultaneous binding of SlmA to DNA 
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and FtsZ, a key cell division protein, which immediately suggests a mechanism for how nucleoid 
occlusion of cell division is achieved by SlmA. This is possibly the most interesting and novel 
aspect of the paper and should be of interest to a general audience, although is is supported by 
SAXS only. 
 
In my opinion, the paper needs to be revised satisfactorily before acceptance. First, there is very 
little actual data presented in the form of figures that relate to the DNA binding experiments. The 
reader comes across sections that effectively state something like: "we did experiment X, and 
therefore we conclude Y". A critical reader will not accept an important conclusion without seeing 
the data. Much of the important data does not even make the supplementary section. The DNA 
binding data should be included (and reviewed) before acceptance. I have tried to offer some 
suggestions further below as to how this data could be presented, while economizing figures 1 and 
2. 
 
Major points: 
 
I. The data for DNA binding specificity experiments need to be shown. 
1. The 43 unique sequences identified by REPSA should be listed in the supplementary section, and 
the MEME method explained briefly, so the reader knows how the consensus was arrived at. 
2. The fluorescence polarization data for SlmA-SBS needs to be shown as a new Fig. 3A. Some of 
the reduced affinity data could also be displayed on the same plot to convince the reader with real 
data. 
3. The current Fig. 3A is inefficient space-wise and could be replaced by a bar-graph showing the 
real data and error bars for the apparent "no binding" sequences. 
4. One mutant sequence is shown as "non-specific" in Fig. 3A, yet how this is different to "no-
binding" is not clear. Again, if the data were shown in a figure the reader could draw their own 
conclusions. 
II. The data for the site mapping in vivo needs to be shown. 
1. The ChIP-seq data should be presented in the form of a graph of sequence read frequency versus 
genome sequence (placed in Fig. 4). One could then visually see the identification of sites and assess 
their statistical significance (the cut-off could be indicated on the graph). 
2. PCR control experiments should be shown in the supplementary section, with the control 
amplifications, that I presume were performed, of regions containing no significant signal in the 
ChIP seq. 
 
Other specific points: 
 
1. Figure 1B is not needed in the main paper: it is just an alignment of previously published 
sequences, it is subsidiary to the main theme of the paper, and it takes a lot of space. With this in the 
supplementary section, Figure 2 could be then merged with Figure 1 and improved. 
2. Fig 2A is poor, with the side-chains hard to see. A magnification of just the dimerization domain 
would be more useful, and would be appropriate to place next to Fig. 1A. 
3. The buffer conditions and standards used for Fig. 2B should be provided in the materials and 
methods. 
4. What is meant by "entrance" in Fig 2D? Would "blocked entrance" be more descriptive? 
5. In figure 4 it would be useful to show the location of oriC on the chromosome maps to clarify 
their locations with respect to the macro-domains. 
6. In Fig. 4B, the absence of SBS in the origin MD of the pathogenic E. coli strains shown deserves 
comment. Why is this so different to K12? Why does the obviously significant clustering differ 
between the strains (it appears to be much more than just the terminal domains that do not contain 
SBS). What is, or could be, the cause of such marked strain differences? 
7. In fig. 5A, the important control curves with FtsZ only and BSA (currently in the sups) should be 
shown on the graph. They would not be obscured by the other data curves, and are just as important 
as the other curves. 
8. In Fig. S4, what models are being fitted here? Include this information in the legend. 
9. It needs to be made clear how the consensus of the best fit models from BUNCH was established. 
The statistical confidence in the accepted model compared with the other possibilities needs to be 
demonstrated. The use of the output of one prediction program as input for yet another creates doubt 
over the validity of the approach. 
10. How can it be ascertained that SlmA blocks interactions between FtsZ protofilaments? (in the 
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molecular model discussion section) This conclusion seems like a leap of faith, as I cannot find data 
in the paper that suggests SlmA blocks one orientation of FtsZ polyermisation over another. 
11. It was noted in the introduction that SlmA was previously found not to reduce FtsZ 
polyermization, but actually enhanced it. This appears to contradict the findings of the current paper, 
and the discrepancy should be addressed. 
 
 
 
 
 
1st Revision - authors' response 15 October 2010 
 
Please find attached our revised manuscript, "Molecular mechanism by which the 
nucleoid occlusion factor, SlmA, keeps cytokinesis in check". We have revised the 
manuscript to comply with all the reviewers requests and also, as you 
recommended, we have provided new data to address SlmAís affect on FtsZ 
polymerization. Specifically, we present exciting new electron microscopy 
experiments, which demonstrate that SlmA significantly alters polymerization by 
FtsZ. These studies show that in the presence of SlmA-DNA, FtsZ forms unique 
and uniform helical structures that are typically 150-200 nm in length. Notably, 
the filamentous FtsZ bundles within these helices exist in a side by side 
orientation that are consistent with our model whereby SlmA-DNA enforces an 
antiparallel arrangement of FtsZ filaments. By contrast, FtsZ alone forms the long 
filamentous structures that have been previously observed by others. Thus, 
these new data unequivocally show that SlmA-DNA drastically affects the 
polymerization properties of FtsZ. Below we address the concerns of the 
reviewers point by point (reviewers comments are in red). 
 
Referee#1 
 
1) When they perform the ChIP-Seq they identified 52 SlmA binding sites on the 
chromosome. It is not clear if having those many points in the chromosome 
would be enough to stop Z-ring formation. Some of these sites might not be on 
the surface of the nucleoid, and therefore hidden to FtsZ. The remaining may be 
restricted to a small region (the extension of their binding site, 12bp x 52 out of 
the 4.6 Mbp chromosome!), making a chance encounter with FtsZ unlikely. The 
authors seem to ignore this issue but they should provide their views about it. 
 
The ChIP method identifies sites that can be bound by the protein in vivo and 
hence are accessible. Unlike Noc, we do not find that SlmA binding to DNA leads 
to spreading to nearby DNA. However, we present new electron microscopy data 
that we believe helps address this issue. Specifically we find that SlmA, when 
bound to SBS DNA, causes dramatic alteration in the polymerization properties of 
FtsZ. In these SlmA-DNA-FtsZ EM samples we never observe the typical FtsZ 
bundles and only see the presence of uniform helical structures. This suggests 
that a small amount of SlmA-DNA is sufficient to inhibit the formation of 
functional FtsZ bundles and further indicates that SlmA-DNA act as nucleation 
sites to promote the growth of non-functional FtsZ helices, which can propagate 
several hundred nm. Notably, SlmA must be bound to SBS DNA to impart this 
effect. However, SlmA is likely always bound to DNA. Indeed, previous studies 
showed that SlmA is localized entirely within the nucleoid fraction of the cell 
(Bernhardt & de Boer, 2005). Moreover, data suggest that DNA binding proteins 
that are not bound to their cognate sites interact non-specifically and slide along 
the DNA or are engaged in rapid dissociation/reassociation from/onto DNA (van 
Noort et al, 1998). Thus, the DNA bound form of SlmA is the physiologically 
relevant form. Because binding to SlmA-DNA does not prevent protofilament 
formation, FtsZ still is in protofilament form but cannot engage in the productive 
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types of polymer interactions that lead to Z-ring formation. Thus, this drastic 
impact on how FtsZ polymers engage is felt at a long distance from each SlmA 
binding site. 
More extended protection of the nucleoid could be provided were the protein not 
to be restricted to the SBS sites. In a recent study of the Bacillus subtilis nucleoid 
occlusion protein, Noc (Wu et al. 2009, EMBO J 28: 1940), it was suggested that 
binding of this protein extends further than its recognition site, covering more 
than 1kb around it. These proteins are very different, Noc is a member of the 
ParB-family known to form filaments on DNA, meanwhile SlmA is not expected to 
do so. On this point is interesting to note that SlmA overexpression has been 
reported to cause FtsZ to localize to the nucleoid (Bernhardt and de Boer 2005, 
Mol. Cell 18: 555), suggesting that the nucleoid can be further loaded with SlmA. 
Regardless of its predicted capacity, the extension of SlmA binding around SBS 
sites, if it does exist, should be evident in the analysis of the ChIP-Seq. This is an 
important attribute of the protein and the authors should be clear about it. 
 
For our ChIP assays, SlmA was expressed at low levels that complement the 
slmA null mutant. As noted above, under these conditions SlmA does not spread 
or extend onto adjacent DNA near its recognition site. This has now been added 
to the manuscript. 
 
2) The authors found that the SBS sites are not homogenously distributed 
throughout the chromosome. Long regions of it lack any of these sequences and 
this seems to be conserved within Enterobacteria. The authors use the 
macrodomain nomenclature of the chromosome to describe the patterns they 
encounter (Espeli and Boccard 2006, J Struct Biol 156:304). This division of the 
chromosome in four discrete and independent regions was proposed by genetic 
and more recently microscopy studies, and implies that each of these 
macrodomains have different behaviours. Following this line of thought, it was 
previously proposed that one way in which SlmA might regulate division is by 
binding to all but the Ter macrodomain (Espeli and Bocard 2006). Tonthat et al. 
when mapping the SBS sites point out that the Ter macrodomain is free of them, 
but they did not mention that in K12 most of the Right macrodomain is also free 
of these sequences (Fig 4A), and in other strains even Ori macrodomain has 
extensive SBS free-zones (Fig 4B). Their results show that Ter macrodomain is 
not the only one with low-density SBS sequences, but they seem to ignore this 
fact. Why should the Right macrodomain be less densly populated by SBSs than 
the Left? The authors should explain these results and incorporate the 
implications in their model. 
 
We have included the fact that the Right and, to a lesser extent, the left MDs 
also appear to have low abundance of SlmA binding sites. We discuss the 
possibility that having few SlmA molecules bound to these MDs, which are 
directly adjacent to Ter, may have a buffering affect to ensure that FtsZ is not 
inhibited from forming Z-rings at this point. This also is suggested by our finding 
that SlmA binding to its DNA sites appears to have long range effects on FtsZ 
polymerization and thus, regions close to Ter may need to be protected from its 
influence. 
 
3) When discussing the distribution of SBS sites on the chromosome, the authors 
consider a link between cell division and segregation. This section is misleading 
since it appears to suggest that there are signals controlling the timing of 
segregation. This goes against the current view on DNA segregation where the 
only factor determining the timing of segregation of a locus is the time of its 
replication (Nielsen et al. 2006, Mol Microbiol 61: 383; Wang et al 2006, Genes 
Dev 20: 1721). This conflict is maybe just a misunderstanding caused by the way 
it is written and may just need rewording of this section. These two processes 
most likely have a passive relation: as the chromosomal regions migrate out of 
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the centre of the cell they push the unreplicated DNA towards midcell, 
positioning the Ter proximal regions at the center of the cell permits the 
formation of the Z-ring. The timing of Z-ring formation can be simply explained 
in terms of the Min system and the position of the Ter proximal regions. To avoid 
confusion the respective lines should be clarified, and more evidence should be 
provided if a direct relation or switch controlling these two processes is 
proposed. 
 
The reviewer is correct. We did not mean to infer that SlmA is an actual "signal". 
We have removed the word signal and have rewritten this section appropriately. 
 
4) An obvious link between cell division and the Ter region is the septal protein 
FtsK. This protein is a DNA translocase needed for resolution of dimer 
chromosomes at dif. The activity of FtsK is restricted to a region of 400 kb 
around dif and requires the septum to be assembled, and possibly also 
constricted (Corre and Louarn 2005, Mol Microbiol 56:1539; Bigot et al 2007, Mol 
Microbiol 64: 1434). Considering the above it follows that for FtsK, as well as for 
the resolution of chromosome dimers, it is essential that the formation of the 
septum may be permitted at the Ter region. The FtsK homologue, SpoIIIE, can 
pump vast sections of the chromosome into the prespore, so an alternative way 
of thinking is that FtsK may serve to protect the Ter region from guillotining (by 
pumping DNA to the correct compartment) and therefore SlmA binding is not 
needed around this region. Given that FtsK and dimer resolution are strongly 
associated to the Ter region the authors should include them intheir discussion. 
 
We have included discussion as recommended. 
 
5) To obtain the structure of SlmA-FtsZ, the authors mixed 1:1 ratio of both 
proteins. In this structure a dimer of SlmA interacts with a pair of FtsZ molecules. 
Nevertheless in their model (Fig 6C & 7) they show a single dimer of SlmA 
interacting with two FtsZ filaments. Although this could be possible, they don't 
discuss the alternative model in which more than one dimer of SlmA is present in 
between the FtsZ protofilaments. They should consider this alternative model or 
provide reasons to discard it. Note that this point relates to the first on the 
extension of SlmA in the regions around SBS sites. 
 
It is possible that several molecules of SlmA could be present between filaments. 
But we donít think this is highly probable given the distance between SBS sites 
on the chromosome and the fact that SlmAís affect on FtsZ polymerization is felt 
at a large distance. We now present data that points to a general model in which 
SlmA-DNA binding to FtsZ protofilaments dramatically alters the assembly of FtsZ 
protofilaments, preventing Z-ring formation. In short, we donít feel that our data 
warrant a highly detailed discussion of how many molecules may be present in 
any unit. 
 
Minor points: 
- At the end of page 5 the authors should use the full name of RMSD 
This has been fixed. 
 
-In page 8 the authors should explain the concept of macrodomains 
before using them for the interpretation of their results 
This is a good point. We have now included the discussion before the 
interpretation as recommended. 
 
- In page 12, it is mentioned that subtle changes in FtsZ polymer 
assembly may prevent Z-ring formation. They should be clearer on the kind of 
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changes they have in mind. 
We now present EM data showing that SlmA-DNA in fact does alter FtsZ 
polymerization. 
 
 
Referee #2 (Remarks to the Author): 
 
The manuscript further characterizes the E. coli nulceoid occlusion protein, SlmA. 
It confirms the previous report by Bernhardt & de Boer that SlmA is a TetR-like 
protein, and that it interacts with the cell division protein FtsZ directly. The 
authors have also identified SlmA binding sequences and shown that, like the 
Bacillus nucleoid occlusion protein Noc, the binding sequences are absent in the 
Ter region. The results presented are very nice, and the manuscript is well 
written. However, a large part of the results are confirmational. This can be 
improved by exploring the in vivo significance of the SlmA crystal structure. The 
authors should verify the dimer interface using mutants on the interface and 
show that the mutant proteins can no longer dimerize, and that the mutants are 
non-functional in vivo. Intercalation of SlmA between FtsZ protofilaments is not 
sufficient to explain the inhibition of FtsZ ring assembly over the nuceloid. 
Although the two FtsZ filaments formed by the FtsZ molecules bound directly to 
the SlmA dimer are anti-parallel and so are not able to interact laterally between 
them, nothing prevents them from forming independent thick parallel filaments 
from the SlmA-free side, unless SlmA dimers come between all growing 
filaments. With only about 50 SlmA dimers scattered on the non-Ter part of the 
chromosome, which is few and far between, this is not very likely. 
The other issue that is not very clear is the role of DNA-binding. The results 
seem to suggest that the role of DNA-binding is purely topological and is not 
required for the activity of SlmA. If so, then any SlmA dimer that is not bound to 
the chromosome will interfere with FtsZ polymerization anywhere in the 
cytoplasm, including the mid-cell. I think the authors need to discuss this 
possibility. 
 
We would first like to point out that TetR family proteins, of which SlmA is a 
member, are all dimeric. Moreover, the dimer interface in SlmA is unusual in that 
it is almost entirely hydrophobic and hence one might expect that disruption of 
such a hydrophobic interface would lead to protein instability. However, as 
recommended, we constructed a dimer mutant. Specifically, we substituted 
three hydrophobic residues in the interface to arginine in hopes that some of the 
protein might be soluble. The mutant protein was found entirely in the pellet. In 
other words the protein was unfolded and as a result, was recovered as inclusion 
bodies (new Supplemental Figure S1A-B). This demonstrates the importance of 
these residues not only in dimerization but that the dimer is required for proper 
protein folding, as is the case with other TetR proteins. 
Indeed, the reviewer is correct that there is nothing to prevent each of the 
antiparallel oriented FtsZ protofilaments, even when bound to SlmA, to form 
parallel lateral interactions. Our new EM data support this in that we see what 
appear to be short bundles of filaments arranged next to each other, which 
would be consistent with this idea. These bundles are very different from the 
extended filamentous structures observed for FtsZ alone with GTP. Thus, the 
data show that that SlmA-DNA dramatically alters the ability of FtsZ to form 
higher order assemblies. In our EM experiments, the ratio of FtsZ to SlmA used 
was 5:1 in an effort to establish conditions close to the physiological state. The 
typical filament bundles formed by FtsZ-GTP were never observed in SlmA-DNAFtsZ 
samples. Indeed, these samples consistently showed only the uniform 
helical structures, now shown in Figure 6C-D. This indicates that a small amount 
of SlmA-DNA is sufficient to inhibit the formation of functional FtsZ bundles and 
further indicates that SlmA-DNA act as nucleation sites to promote the growth of 
a non-functional FtsZ helices, which can propagate several hundred nm. 
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Interestingly, SlmA must be bound to SBS DNA to impart this effect as EM 
samples with FtsZ and SlmA alone or SlmA and non SBS DNA failed to affect FtsZ 
polymer assembly. Our SAXS structure was obtained using a 1:1 ratio of SlmA to 
FtsZ and therefore cannot address how the SlmA DNA binding domain may affect 
the polymerization properties of a growing FtsZ protofilament attached to SlmADNA. 
Like other TetR proteins, the SlmA DNA binding domains are flexible and 
likely only become fixed upon cognate DNA binding. It is probable that the 
precise orientation of the DNA bound form of the SlmA DNA binding domains and 
the DNA itself may be necessary in steering the growing FtsZ protofilaments into 
the specific helical structures we observe. The inability of SlmA alone to affect 
FtsZ polymer assembly could also function as a failsafe measure to prevent 
unwanted perturbation of cytosolic FtsZ polymers where Z-ring assembly is 
desired. However, we stress that it is likely that there is little, if any, SlmA 
present in the cytosol. In fact, previous studies by Bernhardt and de Boer 
showed that SlmA is localized entirely within the nucleoid fraction of the cell. This 
is consistent with previous studies showing that DNA binding proteins that are 
not bound to their cognate sites interact non-specifically and slide along the DNA 
or are engaged in rapid dissociation/reassociation from/onto DNA. Thus, the DNA 
bound form of SlmA is the physiologically relevant form. 
 
Minor points: 
1) Is the His-tag-SlmA used in this study functional in vivo? 
This was demonstrated in vivo previously by Bernhardt and de Boer. But our 
biochemical studies, such as fluorescence polarization also demonstrate that the 
his-tag does not alter function (i.e. we have carried out the experiments using 
protein lacking the his-tag and obtained results that were identical to those 
obtained with the his-tagged protein). 
 
2) Page 3 Introduction, line 15: 'Data show that...' This has been suggested but 
no in vivo data has been shown. 
The sentence has been rewritten. 
 
3) Page 5 last line: give full name for 'RMSD'. 
This has been fixed. 
 
4) Page 6 line 12: what does it mean by 'become induced from their DNA sites'? 
Induce from the DNA refers to (for example the Lac Repressor) that an inducer 
molecule binds and removes the protein from the DNA. This means to dissociate 
the protein from the DNA. We have now altered this sentence to say dissociate 
rather than induce. 
 
5) Page 7, second paragraph about FP assay. Please add 1 or 2 sentences to 
explain the technique. 
A short overview of the FP technique has been added to the Materials and 
Method section. 
 
6) Page 9 second section about SlmA binding to DNA & FtsZ: A control using 
DNA with mutated SlmA binding sites should be included. 
Figure S5 has been added to display a control for SlmA-DNA binding. 
 
7) Page 13 line 12: change 'combined' to 'combining'? this has been corrected. 
8) Page 14 line 8: change 'in to' to 'into'. corrected 
9) Page 14 lines 10 - 13: move the sentence ' Notably.....' to the 'Result' section? 
This has been moved to the Results and Discussion section as recommended. 
10) Figure 6C: the figure legend refers this as 'SAXS structure of SlmA-FtsZ...' 
This is misleading because the SAXS structure does not show FtsZ polymers. 
Should it be referred to as a model? 
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The reviewer is correct. This should be referred to as a model. 
11) Figure legend to Fig 7, the last sentence, and the Abstract: Is it known that 
Z-ring formation requires Z-protofilaments to be in parallel? 
The model that Z-ring formation involves the assembly of parallel arranged FtsZ 
protofilaments is just one model that has been put forth. However, we want to 
point out that it is currently not known how FtsZ protofilaments assemble to form 
a Z-ring. Hence, we have reduced the discussion and clearly pointed out that it is 
currently unknown how FtsZ assembles into Z-rings. 
12) Supp Materials & Methods, line 4: 
Full stop between 'WM3363 WM3363'. corrected 
13) Supp Materials & Methods, line 16: should be 'with', not 'is'. corrected 
14) Figure legend to S2, first line: should be 'into', not 'in to'. corrected 
 
15) The models in FigS5A and Fig 6A are slightly different. Does that indicate 
conformational change upon DNA binding? 
The model in Figure 6A was generated by docking the structure of SlmA and FtsZ 
into the SAXS envelope. The model in Figure S5A (now Figure S12A) was 
generated by extrapolating information regarding the DNA binding capabilities of 
other TetR family members. The DNA binding domain of TetR family members 
are known to be flexible. To dock SlmA HTH onto the DNA required a small 
rotation of the HTH elements indicating that the crystal structure of SlmA 
captured the conformation that is not the "DNA-bound" active conformation. This 
is not surprising as other TetR structures solved in the absence of DNA are also 
not in the precise conformation required for DNA binding suggesting that when 
the proteins bind DNA the HTH elements adjust. For our model we rotated the 
HTH regions with guidance from the QacR-DNA and TetR-DNA structures. The 
legend has been amended to make this point more clear. 
 
16) Do SAXS analyses give information on the interaction interface? 
Although SAXS is a powerful method to provide structural information on large 
macromolecular assemblies when the structures of the individual components 
have already been solved at high resolution, SAXS structures are low resolution 
and only reveal the overall envelopes of the assemblage (~10-20 ≈). Thus, the 
identification of the residues that may be involved in the binding interface of 
SlmA and FtsZ would be an over-interpretation of the data. 
 
 
Referee #3 (Remarks to the Author): 
 
The paper Tonthat et al. is an interesting and significant contribution to its field. 
First, the crystal structure of the E. coli SlmA protein reveals it to be a TetR 
family member. While the structure is very similar to numerous previous 
structures, the novelty here is that it is believed to be the first member of the 
family whose principle role is not in transcriptional regulation. Previous studies 
have shown SlmA to be a "nucleoid occlusion" (NO) factor, which prevents cell 
division from occurring prematurely in the region of the cell occupied by the 
replicating chromosome. To explore the mechanism of SlmA's action, the authors 
identify and characterize the DNA sequence-specific binding of SlmA in vitro. This 
work corresponds well with the author's other approach, which maps the binding 
sites in vivo. These studies need to be presented more rigorously (more on this 
below), but these are important steps in the field. The absence of binding sites in 
the terminus region suggests that once replication/segregation of the 
chromosome has reached this region then NO is releaved in this region of the 
chromosome, which is known to be located near the mid-cell division site at this 
stage of the cell cycle. These findings are new for the E. coli field, although 
similar findings were made previously in the analogous B. subtilis system, as 
acknowledged by the authors. The final part of the paper identifies and 
characterizes the simultaneous binding of SlmA to DNA and FtsZ, a key cell 
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division protein, which immediately suggests a mechanism for how nucleoid 
occlusion of cell division is achieved by SlmA. This is possibly the most 
interesting and novel aspect of the paper and should be of interest to a general 
audience, although is is supported by SAXS only. 
In my opinion, the paper needs to be revised satisfactorily before acceptance. 
First, there is very little actual data presented in the form of figures that relate to 
the DNA binding experiments. The reader comes across sections that effectively 
state something like: "we did experiment X, and therefore we conclude Y". A 
critical reader will not accept an important conclusion without seeing the data. 
Much of the important data does not even make the Supplemental section. The 
DNA binding data should be included (and reviewed) before acceptance. I have 
tried to offer some suggestions further below as to how this data could be 
presented, while economizing figures 1 and 2. 
 
We thank the reviewer for the helpful suggestions, which we have followed as 
outlined below. 
 
Major points: 
I. The data for DNA binding specificity experiments need to be shown. 
1. The 43 unique sequences identified by REPSA should be listed in the 
Supplemental section, and the MEME method explained briefly, so the reader 
knows how the consensus was arrived at. 
 
Figure S4 has been added to display the 43 unique sequences identified by 
REPSA as well as providing a list of sites identified by MEME to contain the SlmA 
binding motif. 
 
2. The fluorescence polarization data for SlmA-SBS needs to be shown as a new 
Fig. 3A. Some of the reduced affinity data could also be displayed on the same 
plot to convince the reader with real data. 
The figure has been revised as suggested. 
 
3. The current Fig. 3A is inefficient space-wise and could be replaced by a bargraph 
showing the real data and error bars for the apparent "no binding" 
sequences. 
The figure has been revised to include all the data (see new Figure 2A). 
 
4. One mutant sequence is shown as "non-specific" in Fig. 3A, yet how this is 
different to "no-binding" is not clear. Again, if the data were shown in a figure 
the reader could draw their own conclusions. 
We apologize for the use of "non-specific". This was a typo, the Kd and 
accompanying curve is displayed in Figure 2A. 
 
II. The data for the site mapping in vivo needs to be shown. The data are now 
included. 
1. The ChIP-seq data should be presented in the form of a graph of sequence 
read frequency versus genome sequence (placed in Fig. 4). One could then 
visually see the identification of sites and assess their statistical significance (the 
cut-off could be indicated on the graph). 
The figure has been modified as suggested. The addition is in Figure S6. 
Additional information on how the statistical methods and cut-off values can be 
found in the Supplemental Materials and methods section. 
 
2. PCR control experiments should be shown in the Supplemental section, with 
the control amplifications, that I presume were performed, of regions containing 
no significant signal in the ChIP seq. 
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Figure S7 has been added to show the control experiments. 
 
Other specific points: 
1. Figure 1B is not needed in the main paper: it is just an alignment of previously 
published sequences, it is subsidiary to the main theme of the paper, and it 
takes a lot of space. With this in the Supplemental section, Figure 2 could be 
then merged with Figure 1 and improved. 
Figure 1 has been revised as suggested. We thank the reviewer for this 
suggestion. 
 
2. Fig 2A is poor, with the side-chains hard to see. A magnification of just the 
dimerization domain would be more useful, and would be appropriate to place 
next to Fig. 1A. 
This has been combined with Figure 1 as suggested. 
 
3. The buffer conditions and standards used for Fig. 2B should be provided in the 
materials and methods. 
This has been included in the Materials and Methods section. 
 
4. What is meant by "entrance" in Fig 2D? Would "blocked entrance" be more 
descriptive? 
This figure has been moved to the Supplemental section Figure S3. The 
descriptor "Blocked" was added for clarification. 
 
5. In figure 4 it would be useful to show the location of oriC on the chromosome 
maps to clarify their locations with respect to the macro-domains. 
This has been added to the corresponding figure (Figure 3). 
 
6. In Fig. 4B, the absence of SBS in the origin MD of the pathogenic E. coli 
strains shown deserves comment. Why is this so different to K12? Why does the 
obviously significant clustering differ between the strains (it appears to be much 
more than just the terminal domains that do not contain SBS). What is, or could 
be, the cause of such marked strain differences? 
The results shown in this figure (now Figure 3B) was obtained from a 
computational search of the chromosomes of pathogenic E. coli with the 
consensus K12 SBS motif. In this in silico analysis, the reviewer noted that the 
distribution of SlmA binding sites are not as equally distributed as it is seen in 
vivo with the K12 strain. However, these other sites (outside K12) are the result 
of predictions only (not experimental). Indeed, the SlmA DNA binding 
preferences may vary slightly from strain to strain. Also, as noted we used the 
consensus SBS motif for the in silico mapping and hence this does not take into 
account the ability of SlmA to bind sites that have some bps that are non 
consensus (as shown in Figure 2). Thus the sites identified computationally are 
not necessarily representative of all the in vivo sites, which may be more 
abundant and distributed. We have tried to emphasize this by using the words 
"predicted" and "putative" to describe the in silico predictions. We do feel that 
these predictions do, however, point out that in all these cases SBS sites are 
notably absent or nearly absent in the Ter MD of pathogenic E. coli strains. 
 
7. In fig. 5A, the important control curves with FtsZ only and BSA (currently in 
the sups) should be shown on the graph. They would not be obscured by the 
other data curves, and are just as important as the other curves. 
These curves were combined as recommended. 
 
8. In Fig. S4, what models are being fitted here? Include this information in the 
legend. 
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The figure legend has been rewritten to clarify the experiment and data 
presented. 
 
9. It needs to be made clear how the consensus of the best fit models from 
BUNCH was established. The statistical confidence in the accepted model 
compared with the other possibilities needs to be demonstrated. The use of the 
output of one prediction program as input for yet another creates doubt over the 
validity of the approach. 
We have now provided more information and detail as to how the SlmA-FtsZ 
model was generated and verified. Briefly, we would like to address the very 
valid point made by the reviewer regarding the use of prediction programs. In 
order to more rigorously explore the many possible conformations of SlmA and 
FtsZ in the SlmA-FtsZ envelope we made the decision not to use the rigid body 
docking built into BUNCH or other programs like it because, in general, these 
programs impose more constraints and tend to be less global. Instead, we 
utilized docking servers, which are more computationally sophisticated. To obtain 
additional verification of modeling, we turned to BUNCH, which compares the 
model with the SAXS curves. The combined results and statistics revealed that 
the model we obtained was the best fit to the data. Indeed, multiple models 
were tried but fit poorly to the data. However, to provide more confidence we 
carried out the additional SAXS experiment, which employed a FtsZ-GFP fusion 
protein. Since SlmA does not bind to the C-terminal tail of FtsZ we generated this 
fusion with the GFP attached to the FtsZ C-terminus. The SAXS envelope of the 
SlmA-FtsZ_GFP protein showed clear density for the GFP molecule and helped 
confirm the best fit. We have also now added more supplemental data to show 
the reader the difference in the fits to the data between the best fit model and 
those that were discarded (Figure S11). 
 
10. How can it be ascertained that SlmA blocks interactions between FtsZ 
protofilaments? (in the molecular model discussion section) This conclusion 
seems like a leap of faith, as I cannot find data in the paper that suggests SlmA 
blocks one orientation of FtsZ polyermisation over another. 
Our new EM experiments demonstrate clearly that SlmA-DNA blocks normal 
assembly of higher order FtsZ polymers. 
 
11. It was noted in the introduction that SlmA was previously found not to 
reduce FtsZ polyermization, but actually enhanced it. This appears to contradict 
the findings of the current paper, and the discrepancy should be addressed. 
Our data do not contradict the previous findings (we also see that FtsZ can form 
filaments in the presence of SlmA) and we think, in fact, explain these previous 
data. Specifically, we show that FtsZ can still form protofilaments when bound to 
SlmA-DNA but the types of polymers are very different. 
 
Again, we thank the reviewers for their helpful comments and hope that we have 
addressed their issues to their satisfaction. 
 
 
 
 
 Acceptance letter 20 October 2010 
Thank you for submitting your revised manuscript for our consideration. I have now 
had a chance to look through it and to assess your responses to the comments 
raised by the original reviewers, and I am happy to inform you that there are no 
further objections towards publication in The EMBO Journal. Before we will able to 
send you a formal letter of acceptance, there are just two minor things I need to ask 
you for: a 'conflict of interest' statement, and an 'author contribution' statement, 
both to be included at the end of the manuscript text. To simplify things, you could 
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simply send them to us in the body of an email, we can easily copy them into the 
manuscript text file; alternatively you can send as a new text document including 
these two statements.  
 
 
 
 
 
 
 
 
 
 
 
 
